Bicycle Therapeutics plc
Bicycle Therapeutics plc (BCYC) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bcyc · stock forecast · 21 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 21 Wall Street analysts in the past 3 months
Buy
21 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$12.00
Consensus
$10.67
+154.0% upside
Low
$8.00
Median: $12 · Last Close: $4.20
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$10.67
154.0% upside
High Target
$12
185.7%
Low Target
$8
90.5%
Current Price
$4.20
as of today
Based on analyst price targets, the BCYC stock price prediction for the next 12 months ranges from $8 to $12. The consensus BCYC price forecast of $10.67 implies 154.0% upside from the current price of $4.20.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.09 | ↓ 2.67% |
1-day model range: $4.04–$4.13. Peak: $4.13 (-2.67%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · BCYC · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-08 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2026-03-18 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2026-03-18 | Needham | Maintains | Buy→Buy |
| 2026-03-18 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-03-18 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-10-31 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-10-31 | RBC Capital | Downgrade ↓ | Outperform→Sector Perform |
| 2025-08-12 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2025-08-12 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-08-11 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Bicycle Therapeutics plc (BCYC) stock. Of the recent 106 rating actions, 3 were upgrades and 3 were downgrades. 21 analysts currently cover BCYC.
Analyst Recommendation Trends
BCYC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$22M
↓ 61.5% YoY
Revenue Next Year
$15M
↓ 32.7% YoY
EPS This Year
$-2.31
EPS Next Year
$-2.36
↑ 2.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast BCYC EPS of $-2.31 for the current fiscal year, based on estimates from 8 analysts. The BCYC revenue forecast is $22M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BCYC stock forecast is supported by two independent data sources: analyst consensus ratings from 21 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BCYC price target is $10.67 (+154.0% upside), with an analyst consensus of Buy.
The BCYC short-term stock prediction for tomorrow is $4.09 (-2.67%). The BCYC stock prediction for 2030 projects a range of $1–$1.
Bicycle Therapeutics plc trades on NASDAQ under the ticker BCYC. The BCYC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 81% of covering analysts.
Frequently asked questions
BCYC forecast · 8 questionsAccording to 21 Wall Street analysts, the average 12-month BCYC price target is $10.67, with a high forecast of $12.00 and a low of $8.00. The median price target is shown in the chart above when available. This implies +154.0% potential upside from the current price of $4.20.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.